Perbedaan UBC Medical Indonesia Tbk. dan Saraswanti Indoland Development Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Saraswanti Indoland Development Tbk. diperdagangkan di Rp113 (kapitalisasi pasar 576,2 M, volume 24 jam 164,77 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. dan Saraswanti Indoland Development Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Saraswanti Indoland Development Tbk. lebih aktif diperdagangkan (164,77 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | SWID | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 576,2 M |
Volume | 843 rb | 164,77 jt |
Lot | 8,43 rb | 1,65 jt |
Perputaran | 137,6 jt | 19,28 M |
Harga Rata-rata | 163,22 | 117,01 |
Nilai Transaksi | 137,6 jt | 19,28 M |
Harga Ekuilibrium Indikatif | 165 | 113 |
Volume Ekuilibrium Indikatif | 246 | 11,44 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Selengkapnya di halaman SWID →